StepStone Group LP's Amendment to Schedule 13D for NeueHealth, Inc.


2025-10-06SEC Filing SCHEDULE 13D/A (0001193125-25-232031)

StepStone Group LP has filed an amendment to its Schedule 13D for NeueHealth, Inc., indicating that all shares of Common Stock held by the Reporting Persons were canceled and extinguished on October 2, 2025, in connection with the issuer's previously announced business combination. As a result, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Common Stock. The amendment includes details on the conversion of shares into cash at $7.33 per share and the cessation of significant ownership. The filing is signed by Jennifer Y. Ishiguro, Partner and Chief Legal Officer of StepStone Group Holdings LLC.


Tickers mentioned in this filing:NEUE